Factors | Overall survival | ||||
---|---|---|---|---|---|
Number | Mean(months) | 95%CI | χ 2 | P | |
All patients | 180 | 13 | 10.9-15.1 | Â | Â |
Sex | Â | Â | Â | 2.386 | 0.122 |
 Male | 123 | 14 | 11.7-16.3 |  |  |
 Female | 57 | 11 | 6.4-15.6 |  |  |
Age | Â | Â | Â | 0.466 | 0.495 |
  ≤ 50 | 32 | 16 | 11.2-20.8 |  |  |
 >50 | 148 | 13 | 11.0-15.0 |  |  |
Site | Â | Â | Â | 0.520 | 0.771 |
 Gastrointestinal tract | 143 | 13.5 | 11.8-15.2 |  |  |
 Pancreas | 13 | 8 | 5.0-11.0 |  |  |
 Others | 24 | 12 | 2.9-21.1 |  |  |
Differentiation | Â | Â | Â | 9.186 | 0.002 |
 NEC | 137 | 11 | 8.5-13.5 |  |  |
 NET G3 | 30 | 34 | 10.7-57.3 |  |  |
Metastasis | Â | Â | Â | 85.305 | 0.000 |
 Local | 48 | 36 | 25.9-46.1 |  |  |
 Loco-reginal | 45 | 15 | 13.9-16.2 |  |  |
 Distant | 71 | 6 | 4.7-7.3 |  |  |